RxDoctor Payments Data

Richard Hill, MD

Urogynecology and Reconstructive Pelvic Surgery · Kansas City, MONPI 1144212424

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,351 of the $2,824 with a category attached, or 83.3%. Axonics, Inc. accounts for 60.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $777 and has fallen 66.1% since, to $263 in 2025.

$2,824in general payments, 2019–2025

Across 58 payments — averaging $48.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Boston Scientific$523
  • Coloplast$294
  • Caldera Medical, Inc$172
  • AbbVie$91
  • Valencia Technologies Corporation$37

What the payments were for

  • Speaking & faculty fees$47317%
  • Food & beverage$2,35183%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,824 in reported general payments places this provider in the 60th percentile of 21 urogynecology and reconstructive pelvic surgery providers in Missouri.

See all urogynecology and reconstructive pelvic surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$163,838
Medicare patients
204
Services billed
833

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron85$59,861
Estradiol200$13,567
GemtesaVibegron17$13,526
Methenamine Hippurate133$12,063
PremarinEstrogens, Conjugated27$11,057
Solifenacin Succinate84$4,903
Tolterodine Tartrate ErTolterodine Tartrate24$2,041
Oxybutynin Chloride ErOxybutynin Chloride136$1,834
Fesoterodine Fumarate ErFesoterodine Fumarate13$1,390
Clobetasol Propionate23$1,339
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst82$1,137
Trospium Chloride14$1,105
Halobetasol Propionate17$1,096
Cephalexin143$761
Tamsulosin Hcl81$693

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →